This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Analysts Offer Insights on Healthcare Companies: Disc Medicine (IRON) and Celcuity (CELC)

Tipranks - Tipranks - Wed Jun 3, 12:44PM CDT

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Disc Medicine (IRON) and Celcuity (CELC) with bullish sentiments.

Claim 55% Off TipRanks

Disc Medicine (IRON)

H.C. Wainwright analyst Douglas Tsao reiterated a Buy rating on Disc Medicine today and set a price target of $118.00. The company’s shares closed last Tuesday at $68.39, close to its 52-week high of $68.73.

According to TipRanks.com, Tsao is a 5-star analyst with an average return of 20.8% and a 52.8% success rate. Tsao covers the Healthcare sector, focusing on stocks such as Rapport Therapeutics, Inc., Neumora Therapeutics, Inc., and Praxis Precision Medicines. ;'>

Currently, the analyst consensus on Disc Medicine is a Strong Buy with an average price target of $100.63, representing a 41.5% upside. In a report released today, LifeSci Capital also maintained a Buy rating on the stock with a $100.00 price target.

See the top stocks recommended by analysts >>

Celcuity (CELC)

Needham analyst Gil Blum reiterated a Buy rating on Celcuity today and set a price target of $157.00. The company’s shares closed last Tuesday at $93.08.

According to TipRanks.com, Blum is a 5-star analyst with an average return of 13.8% and a 43.8% success rate. Blum covers the Healthcare sector, focusing on stocks such as Artiva Biotherapeutics, Inc., Mereo Biopharma Group Plc, and Recursion Pharmaceuticals. ;'>

Currently, the analyst consensus on Celcuity is a Strong Buy with an average price target of $172.38, an 81.5% upside from current levels. In a report released today, LifeSci Capital also maintained a Buy rating on the stock with a $165.00 price target.

Read More on IRON:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).